company-logo

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Novartis Dividend Announcement

Novartis announced a semi annually dividend of $3.78 per ordinary share which will be made payable on . Ex dividend date: 2024-09-24
Novartis annual dividend for 2024 was $7.55
Novartis annual dividend for 2023 was $3.47
Novartis's trailing twelve-month (TTM) dividend yield is 7.33%
Novartis's payout ratio for the trailing twelve months (TTM) is 43.31%
Novartis's dividend growth over the last five years (2018-2023) was 5.40% year
Novartis's dividend growth over the last ten years (2013-2023) was 4.35% year

Novartis Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-09-24$3.78semi annually
2024-03-07$3.78semi annually2024-04-19
2023-03-09$3.47semi annually2023-03-20
2022-03-08$3.36semi annually2022-03-17
2021-03-04$3.38semi annually2021-03-15
2020-03-03$3.04semi annually2020-03-12
2019-03-04$2.57semi annually2019-03-13
2018-03-06$2.67semi annually2018-04-25
2017-03-01$2.46semi annually2017-04-20
2016-02-24$2.47semi annually2016-04-15
2015-03-02$2.52semi annually2015-04-20
2014-02-27$2.72semi annually2014-04-10
2013-02-26$2.27semi annually2013-04-05

Novartis Dividend per year

Novartis Dividend growth

Novartis Dividend Yield

Novartis current trailing twelve-month (TTM) dividend yield is 7.33%. Interested in purchasing Novartis stock? Use our calculator to estimate your expected dividend yield:

Novartis Financial Ratios

P/E ratio11.78
PEG ratio-0.31
P/B ratio4.79
ROE41.08%
Payout ratio43.31%
Current ratio1.11
Quick ratio0.90
Cash Ratio0.48

Novartis Dividend FAQ

How much is the next Novartis dividend?
Novartis's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Novartis dividend. The next Novartis dividend will be released in March.
When is Novartis dividend paid?
Novartis pays dividends on a semi annually basis. The specific dates may vary each year but are generally around March. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Novartis pay?
The specific amount of Novartis dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Novartis's dividend history.
Does Novartis stock pay dividends?
Yes, Novartis does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Novartis's dividend history.
How much dividend does Novartis pay?
Novartis paid $7.554 in 2024, $3.469 in 2023, $3.357 in 2022, $3.378 in 2021, and $3.042 in 2020.
How often does Novartis pay dividends?
Novartis typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around March.
What is Novartis's dividend yield?
The current dividend yield for Novartis is 7.33%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Novartis's exact dividend yield.
When does Novartis go ex dividend?
Novartis's ex-dividend date for the latest dividend was on 2024-09-24. Novartis typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Novartis dividend paid?
Novartis pays dividends on a semi annually basis, typically around March, but the exact dates can vary each year.
Will Novartis increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Novartis will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Novartis dividend per share?
Novartis paid $7.554 per share in 2024 and $3.469 per share in 2023. The amount of dividend per share that Novartis pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Novartis a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Novartis a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Novartis a dividend stock?
Yes, Novartis is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Novartis a good dividend stock?
Whether Novartis is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Novartis has a history of paying regular dividends, which can make it attractive to income-focused investors.

Other factors to consider when evaluating Novartis as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Novartis pay dividends monthly?
Novartis typically pays dividends on a semi annually basis.
Does Novartis pay dividends quarterly?
Novartis currently pays dividends on a semi annually basis.
Has Novartis ever paid a dividend?
Yes, Novartis has a history of paying dividends to its shareholders. Novartis is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Novartis dividend stocks?
To buy Novartis you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.

Place an order: Use the brokerage's trading platform to place an order to buy Novartis stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Novartis pay dividends 2024?
Novartis pays dividends on a semi annually basis. 2024 dividend payments are in . However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Novartis increase its dividend in 2024?
Decisions regarding Novartis dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Novartis dividend overview you can look into the above table of dividend history.
How Novartis dividend works?
The Novartis dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Novartis's dividend process works:

1. Determination of Dividend: Novartis's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.

2. Dividend Declaration: Once the board approves a dividend, Novartis publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.

3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.

4. Payment Date: On the designated payment date, Novartis distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.

5. Tax Implications: Dividends received from Novartis are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Novartis dividends paid?
Novartis dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:

1. Record Date: Novartis sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.

2. Payment Date: On the designated payment date, Novartis distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.

3. Currency: Novartis declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Novartis pay dividends?
Novartis typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Novartis pay dividends?
The general pattern is that Novartis pays dividends around March. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Novartis dividend safe?
The safety of Novartis's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.

To assess the safety of Novartis's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.

It is recommended to review Novartis's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.